Evaluation and management of non-alcoholic steatohepatitis.
Non-alcoholic fatty liver disease represents a spectrum of liver diseases which occurs in the absence of alcohol consumption in amounts considered injurious to the liver. Non-alcoholic fatty liver disease includes both non-alcoholic fatty liver and non-alcoholic steatohepatitis. We present an integrated approach that utilizes both clinical and laboratory studies to diagnose and manage a patient with suspected non-alcoholic steatohepatitis. The goals of treatment include (1) correction of the underlying risk factors, (2) avoidance of factors that promote progression of liver disease, and (3) specific treatment of non-alcoholic steatohepatitis.
Reid
B Marie
BM
Division of Gastroenterology, Hepatology and Nutrition, Dept of Internal Medicine, Virginia Commonwealth University, Richmond, USA.
Sanyal
Arun J
AJ
D048909:Diabetes Complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005234:Fatty Liver / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D006505:Hepatitis / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D006801:Humans; D006973:Hypertension / Q000150:complications; D008099:Liver / Q000201:enzymology / Q000473:pathology; D009765:Obesity / Q000150:complications; D011379:Prognosis; D012307:Risk Factors